TP53 wt Allele Recruiting Phase 1 Trials for AMG-232 (DB15299)

IndicationStatusPhase
DBCOND0082200 (TP53 wt Allele)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03107780MDM2 Inhibitor AMG-232 in Treating Patients With Recurrent or Newly Diagnosed GlioblastomaTreatment
NCT03041688KRT-232 (AMG-232) and Decitabine in Treating Patients With Relapsed, Refractory, or Newly-Diagnosed Acute Myeloid LeukemiaTreatment